Page 9 of Cipla News: Cipla Latest News, Cipla Today news, Cipla Breaking News

Stocks that are in focus today: Cipla, ONGC, Wipro and more

Cipla stocks will be in focus today as the the Indian generic drugmaker on Friday informed BSE that its UK…

Updated: September 4, 2015 10:16 IST

Cipla to buy two US generics firms InvaGen Pharmaceuticals, Exelan Pharmaceuticals for $550 mn

Indian generic drugmaker Cipla on Friday informed the Bombay Stock Exchane that its UK arm, Cipla EU has entered into…

Updated: September 4, 2015 11:04 IST

Cipla to acquire US-based InvaGen Pharmaceuticals and Exelan Pharmaceuticals

Signs agreements to acquire 100 per cent of generic businesses in the US for $550 million Cipla’s UK arm, Cipla…

September 4, 2015 09:13 IST

Cipla appoints Umang Vohra and Prabir Jha to its management team

Vohra will be the global chief financial and strategy officer and Jha will take over as global chief people officer…

Updated: September 2, 2015 14:07 IST

Stocks in focus today: DLF, Tata Motors and more

Tata Motors’ stocks will be in focus as the company on Tuesday said its August growth remained flat at 40,680…

Updated: September 2, 2015 10:23 IST

Cipla gains 3 per cent on strong revenue outlook

Shares of Cipla on Friday soared nearly 3 per cent in morning trade on bourses after the company said it…

Updated: August 28, 2015 17:59 IST

Cipla urges government to support capital investment, R&D for pharma industry

Recommends creating a favourable tax regime to help growth of the pharma industry

August 24, 2015 13:59 IST

Sensex companies’ Q1 profit grew by around 1% YoY

Net profit of the Sensex companies grew by around 1 per cent year-on-year (YoY) for the previous quarter ended June…

Updated: August 18, 2015 14:28 IST

Cipla announces Q1 FY15-16 unaudited consolidated financial results

Profit after tax grew by 120.9 per cent to Rs 651 crore, up from Rs 295 crore Cipla has announced…

August 17, 2015 10:32 IST

Cipla Q1 net profit zooms over two-fold to Rs 651 cr

Drug major Cipla today reported an over two-fold jump in its consolidated net profit to Rs 650.61 crore for the…

Updated: August 14, 2015 21:34 IST

Cipla to launch new respiratory inhaler Synchrobreathe

Will be beneficial for physicians, patients and healthcare providers on managing OBD

August 11, 2015 16:33 IST

Cipla announces investment led by Fidelity Growth Partners India for consumer healthcare business

The business will focus on opportunities arising from the shift from illness to wellness and self-care Cipla’s board has approved…

July 21, 2015 13:54 IST

Cipla appoints Samina Vaziralli onto the Board of Directors

Cipla has appointed Samina Vaziralli as Executive Director on its board. Vaziralli is the daughter of MK Hamied, Vice Chairman…

Updated: July 10, 2015 14:22 IST

Initiate ‘sell’ on Cipla as risks outweigh likely rewards

Cipla’s decade-long effort on inhaler development may finally bear fruit over the next five years.

July 2, 2015 00:16 IST

Cipla, BMS settle Hepatitis B drug dispute out of court

The patent dispute between US-based pharma major Bristol-Myers Squibb (BMS) and Cipla over Entecavir…

June 18, 2015 00:26 IST

Stempeutics receives Japan process patent for its stem cell drug ‘Stempeucel’

Stempeucel is derived from allogeneic pooled mesenchymal stromal cells extracted from the bone marrow of healthy, adult voluntary donors, is…

June 8, 2015 13:46 IST

Cipla gets US FDA approval for Lopinavir and ritonavir oral pellets

These are used for the treatment of AIDS in infants and young children

June 3, 2015 17:01 IST

Maintain buy on Cipla with revised price target of Rs 750: Edelweiss

Cipla’sQ4FY15 Ebitda margin (16.4%) was below estimate with consolidation of acquired entities and bunching up of R&D diluting…

June 2, 2015 00:10 IST

Page 9 of Cipla

Related News

Photo Gallery

Dehradun drowns: Cloudburst triggers chaos amid floods; Rivers swell, vehicles swept away – In Photos

Trending Topics